News
REGENXBIO Inc. (Nasdaq: RGNX) today announced the publication of preclinical results comparing a microdystrophin gene therapy construct that included the C-terminal (CT) domain to a microdystrophin ...
REGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Microdystrophin Construct in RGX-202 Investigational Gene Therapy for Duchenne Muscular Dystrophy ...
The Tennessee Volunteers hosted many players on campus recently, including their linebacker commit Braylon Outlaw, who recently shut down his recruitment. The t ...
Legendary country and folk icons are making a stop in Texas as part of the Outlaw Music Festival tour. Here’s your guide to tickets, parking and more.
These songs put the "outlaw" in Outlaw Country. From gunfights to near-misses with federal agents, these tunes have it all.
In our Hypnospace Outlaw review, Andy Kelly called it "a cyber-detective adventure set within a fictional computer operating system", with an alternate 1999 setting let you explore a nostalgic ...
Dead Outlaw will play its final performance on Broadway on Sunday, June 29, producers announced today.
RGX-202 shows promising efficacy in Duchenne muscular dystrophy, improving functional outcomes and biomarker expression in early trial results.
Based on the story of Sooner State robber-turned-mummy Elmer McCurdy, "Dead Outlaw" went into the June 8 Tonys nominated for seven awards.
Explore REGENXBIO's RGX-121 gene therapy for Hunter syndrome, with an FDA decision due Nov 9, 2025. Click here to read my most recent analysis.
The Tennessee Volunteers received some great news on the recruiting trail as their linebacker commit, Braylon Outlaw from Pike Road, Alabama, is putting a big orange lock on his recruitment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results